NCT03398629 Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
| NCT ID | NCT03398629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou Women and Children's Medical Center |
| Condition | Intrauterine Growth Restriction |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2019-05-01 |
| Primary Completion | 2038-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2019-05-01 with a primary completion date of 2038-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this prospective cohort study is to build a large platform that includes clinical information (prenatal diagnosis and postnatal follow-up data) and biological specimen banks of fetuses/infants with IUGR or congenital anomalies, which provide vital support and research foundation for accurate diagnosis, precision treatment and meticulous management.
Eligibility Criteria
Inclusion Criteria: All pregnant women who present to Guangzhou Women and Children's Medical Center meeting one of the following prenatal diagnoses and neonates/infants who are diagnosed as one of the following anomalies will be invited to participate: 1. Intrauterine growth restriction (IUGR) 2. Structural anomaly 3. Chromosomal anomaly Exclusion Criteria: 1. Pregnant women who don't agree to participate; 2. Pregnant women delivering babies at other hospitals. 3. Prenatally suspected anomalies that are not confirmed by postnatal diagnosis.
Contact & Investigator
Wei Zhong, Master
PRINCIPAL INVESTIGATOR
Guangzhou Women and Children's Medical Center
Frequently Asked Questions
Who can join the NCT03398629 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Intrauterine Growth Restriction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03398629 currently recruiting?
Yes, NCT03398629 is actively recruiting participants. Contact the research team at zhongwei@gwcmc.org for enrollment information.
Where is the NCT03398629 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT03398629 clinical trial?
NCT03398629 is sponsored by Guangzhou Women and Children's Medical Center. The principal investigator is Wei Zhong, Master at Guangzhou Women and Children's Medical Center. The trial plans to enroll 10,000 participants.